71. The #1 Mistake Founders Make With Their Startups

Timothy Blair has spent more than 30 years inside some of the most influential companies in MedTech. But when he was offered a multimillion-dollar deal that could have accelerated everything, he walked away.In this episode, Tim shares why he turned down funding that most founders would have taken. He explains how early-stage deals can quietly dismantle a company’s future and what it takes to grow without losing control. From managing investor pressure to building a high-performance team culture, this is a real look at leadership inside a startup committed to doing things differently.We also talk about why so many startups burn through capital too quickly, how to avoid hiring the wrong people, and what founders often overlook when the stakes get high.🎧 Founders, operators, and investors will find plenty to take away from this conversation. 00:00 Meet Tim Blair03:10 The funding offer that could have changed everything07:42 What startups get wrong about early growth11:05 Managing pressure from investors and boards16:30 How VC capital can put a company at risk21:55 Building a team with a strict culture fit26:12 Why he only hires people with hunger and resilience30:40 What investors actually look for in a founding team34:50 How founders lose control of their own company38:45 Surviving the early months without a paycheck45:00 Capital discipline and protecting your original investors51:10 What’s next for ICHOR Vascular💡 Who Should ListenThis episode is for startup founders, operators, and healthcare entrepreneurs thinking critically about how they raise money, grow a team, and build something that lasts. It is especially relevant for those working in MedTech or highly regulated sectors, and for anyone questioning the conventional path to startup growth.About Tim BlairTim Blair is the CEO and Co-Founder of ICHOR Vascular Inc., a company developing novel approaches to thrombectomy in the peripheral vascular system. He has more than 33 years of experience in the medical device industry, with leadership roles spanning sales, marketing, executive management, clinical and regulatory strategy, and fundraising.His background includes positions at Smiths Medical, AngioDynamics, and NAMSA, where he helped scale one of the world’s largest medical device testing and evaluation firms. He has also led and supported M&A targeting, private equity and venture capital due diligence, and serves as an advisor to several emerging startups in the cardiovascular space.Connect with Tim💼 LinkedIn: ⁠⁠Timothy Scott Blair⁠⁠🌐 ICHOR Vascular Inc: ⁠⁠https://ichorvascular.com/⁠⁠Follow Life of Flow📲 Instagram: ⁠⁠@LifeofFlowPodcast⁠⁠👍 Facebook: ⁠⁠Life of Flow Podcast⁠⁠💼 LinkedIn: ⁠⁠Life of Flow Podcast⁠⁠🐦 X: ⁠⁠@VascularPodcast⁠⁠If this episode gave you a new perspective, send it to someone building something of their own. Follow the show for more conversations like this.